Bldy good business Today, Thyrocare Technologies, the company Velumani founded, is valued by outside investors at Rs 500 crore and has many private equity suitors thanks to the returns
A science graduate who had later done a Master's and doctoral thesis on the thyroid, Velumani had to fall back on his provident fund corpus, a princely Rs 95,000, to build the lab. With thyroid testing done mostly for women, it was logical to bung in tests for fertility, pregnancy, etc., once t...
Saved in:
Published in | Business today (New Delhi, India) |
---|---|
Main Author | |
Format | Magazine Article |
Language | English |
Published |
New Delhi
Living Media India, Limited
04.10.2009
|
Online Access | Get full text |
Cover
Loading…
Summary: | A science graduate who had later done a Master's and doctoral thesis on the thyroid, Velumani had to fall back on his provident fund corpus, a princely Rs 95,000, to build the lab. With thyroid testing done mostly for women, it was logical to bung in tests for fertility, pregnancy, etc., once the lab's business stabilised. Today, Thyrocare Technologies, the company Velumani founded, is valued by outside investors at Rs 500 crore and has many private equity suitors thanks to the returns: a profit of Rs 30 crore on a turnover of just Rs 50 crore. But Velumani is not in a hurry to borrow or take PE partners. |
---|---|
Bibliography: | ObjectType-News-1 content type line 24 SourceType-Magazines-1 |
ISSN: | 0974-3650 |